Plexium

Plexium

Biotechnology Research 9330 Scranton Road 62 employees
Employees
62
Contacts
4
Emails
4
Phones
2

Plexium Overview

Headquarters
9330 Scranton Road
Website
plexium.com
Industry
Biotechnology Research
Employees
62
Founded
2018
Funding
102.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Plexium

Plexium is the premier, next-generation targeted protein degradation company, seeking to discover a wide range of monovalent target protein degraders that address the limitations of PROTACs and cereblon. The company’s platform is a proprietary drug discovery platform designed to identify novel small molecules that induce selective degradation of drug target proteins through E3 ligase mediated proteasomal degradation. From molecular glues to monovalent degraders, Plexium is advancing a pipeline of novel targeted protein degraders for the treatment of cancer, neurodegeneration, and other diseases.

Plexium Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Plexium Org Chart

Sample employees and titles
Name Title Contact
Sean Murphy Sr. Director at Plexium
Email
Luis A. Lopez Scientist at Plexium
Email
Swaroop Kolluri Founder & Managing Director, Neotribe
Email Phone
Stephen Mullennix Chief Financial Officer at Plexium, Inc.
Email Phone

Employees by Management Level

Individual contributor 7 profiles
Executive 4 profiles
Senior / Lead 3 profiles
Associate / junior 3 profiles
Director 1 profile
Manager 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 7 7 2
Finance 2 2 0
IT 1 1 0

Plexium Tech Stack

Data / AI 4 profiles
Engineering 1 profile

Compare Similar Companies to Plexium